Liver Transplantation

Article	Citations
Racial, Gender, and Socioeconomic Disparities in Liver Transplantation	75
Sequential Use of Normothermic Regional and Ex Situ Machine Perfusion in Donation After Circulatory Death Liver Transplant	55
Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients	51
A Review of the Current State of Liver Transplantation Disparities	51
Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria	41
The Stanford Integrated Psychosocial Assessment for Transplant Is Associated With Outcomes Before and After Liver Transplantation	41
Sarcopenia in Children With End‐Stage Liver Disease on the Transplant Waiting List	41
Hypothermic Oxygenated Perfusion Improves Extended Criteria Donor Liver Graft Function and Reduces Duration of Hospitalization Without Extra Cost: The PERPHO Study	40
Liver Transplantation for Acute Intermittent Porphyria	39
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes	39
The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End‐Stage Liver Disease Scores and Exception Statuses	37
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin	36
Introducing EL‐FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates	36
A 6‐Month Report on the Impact of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Acuity Circles Policy Change	35
The Emerging Role of Viability Testing During Liver Machine Perfusion	33
Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine‐Based and Cystatin C–Based Equations: Systematic Review and Meta‐Analysis	32
Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	32
Immunogenicity and Adverse Effects of the 2‐Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients	31
Similar Results in Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion and Donation After Brain Death Donors: A Case‐Matched Single‐Cente	31
Higher Mortality in Pediatric Liver Transplant Candidates With Sarcopenia	30
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors	30
Financial burden in adults with chronic liver disease: A scoping review	29
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach	29
Post–Liver Transplant Acute Kidney Injury	28
External Validation of the VOCAL‐Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems	26

Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis	26
In situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death	26
Multicenter study of racial and ethnic inequities in liver transplantation evaluation: Understanding mechanisms and identifying solutions	25
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	25
A review of racial, socioeconomic, and geographic disparities in pediatric liver transplantation	25
Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes	25
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	24
Variation in Racial Disparities in Liver Transplant Outcomes Across Transplant Centers in the United States	24
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma	24
Clinical Factors Associated With Lack of Serological Response to SARS‐CoV‐2 Messenger RNA Vaccine in Liver Transplantation Recipients	23
Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID‐19: A Multicenter Cohort	23
Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss	22
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	22
The Predictive Role of Model for End‐Stage Liver Disease–Lactate and Lactate Clearance for In‐Hospital Mortality Among a National Cirrhosis Cohort	22
Guillain‐Barré Syndrome After COVID‐19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response	21
Donor Morbidity Is Equivalent Between Right and Left Hepatectomy for Living Liver Donation: A Meta‐Analysis	21
Liver transplantation of partial grafts after ex situ splitting during hypothermic oxygenated perfusion—The HOPE–Split pilot study	21
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients	21
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants	21
Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome	20
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	20
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis	20
The Impact of the 2017 Kidney Allocation Policy Change on Simultaneous Liver‐Kidney Utilization and Outcomes	20
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	20
Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care	20
Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension	20
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	19
Pretransplant Intensive Care Unit Management and Selection of Grade 3 Acute‐on‐Chronic Liver Failure Transplant Candidates	19
Regulatory T Cell Therapy Following Liver Transplantation	19
Minimally Invasive Living Donor Liver Transplantation: Pure Laparoscopic Explant Hepatectomy and Graft Implantation Using Upper Midline Incision	19
Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium	19
Location and allocation	18
Identifying Modifiable Predictors of Long‐Term Survival in Liver Transplant Recipients With Diabetes Mellitus Using Machine Learning	18
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria	18
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta‐Analysis	18
Steroid‐Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination	18
Outcomes of Coronavirus Disease 2019 in Living Donor Liver Transplant Recipients	18
The Current Landscape of Liver Transplantation After Ex Situ Machine Perfusion and Normothermic Regional Perfusion in the United States	18
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study	18
Laparoscopic Living Donor Right Hepatectomy Regarding the Anatomical Variation of the Portal Vein: A Propensity Score–Matched Analysis	17
Intraoperative risk factors of acute kidney injury after liver transplantation	17
Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis	17
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States	17
Liver Transplantation in Children with Urea Cycle Disorders: The Importance of Minimizing Waiting Time	17
Complete transition from open surgery to laparoscopy: 8‐year experience with more than 500 laparoscopic living donor hepatectomies	17
Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial	17
A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients	16
Superior Long‐Term Outcomes of Adult Living Donor Liver Transplantation	16
Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States	16
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution	16

Renal Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US Multicenter Simultaneous Liver‐Kidney Transplantation Consortium	16
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	15
Survival Benefit of Split‐Liver Transplantation for Pediatric and Adult Candidates	15
Acute Liver Failure Etiology Is an Independent Predictor of Waitlist Outcome but Not Posttransplantation Survival in a National Cohort	15
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis	15
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers	15
Cardiac Risk Stratification in Liver Transplantation: Results of a Tiered Assessment Protocol Based on Traditional Cardiovascular Risk Factors	15
Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation	15
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure	15
Black patients and women have reduced access to liver transplantation for alcohol‐associated liver disease	15
The Impact of Median Model for End‐Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma	15
National Trends in Location of Death in Patients With End‐Stage Liver Disease	15
Technical Choices in Pediatric Living Donor Liver Transplantation: The Path to Reduce Vascular Complications and Improve Survival	15
Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy?	15
Donation after circulatory death transplant outcomes using livers recovered by local surgeons	15
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival	14
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	14
Propensity Score–Matched Analysis of Posttransplant Outcomes in Living Donor Liver Transplantation for Older Adult Recipients	14
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver‐Kidney Allocation Policy	14
Center use of technical variant grafts varies widely and impacts pediatric liver transplant waitlist and recipient outcomes in the United States	14
Can Living Donor Liver Transplantation in the United States Reach Its Potential?	14
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion	14
Histidine‐Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis	14
The Future of Quality Improvement for Cirrhosis	14
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	14
Early Survivorship After Liver Transplantation	14
Redefining Success After Liver Transplantation: From Mortality Toward Function and Fulfillment	13
Caregiver perspectives on the everyday medical and social needs of long‐term pediatric liver transplant patients	13
Role of Novel Kidney Biomarkers in Patients With Cirrhosis and After Liver Transplantation	13
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	13
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry	13
What Liver Transplant Recipients Want in a Smartphone Intervention to Enhance Recovery: Prototype for the LiveRight Transplant App	13
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion	13
Interleukin‐10 and Transforming Growth Factor‐β Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver	13
Medicaid Expansion Association With End‐Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage	13
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study	13
Is Blood Transfusion a Means of False Positive Phosphatidylethanol Testing?	12
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30	12
Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements	12
Cardiac Risk Assessment in Liver Transplant Candidates	12
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transpla	12
Hypothermic oxygenated machine perfusion as a tool to facilitate liver transplantation in the acute‐on‐chronic liver failure scenario	12
Cannabinoid Use Among Liver Transplant Recipients	12
Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and meta-analysis	12
Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries	12
Efficacy and Safety of Endoscopic Balloon Placement for Weight Loss in Patients With Cirrhosis Awaiting Liver Transplantation	12
What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model	12
Secondary Prophylaxis of Gastric Variceal Bleeding: A Systematic Review and Network Meta‐Analysis	12
Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites	12
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	11
Autoimmune hepatitis presenting as acute liver failure: A 20-year retrospective review of North America	11
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation	11
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation	11
Portal Vein Complications After Adult Living Donor Liver Transplantation: Time of Onset and Deformity Patterns Affect Long‐Term Outcomes	11
AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study	11
Demarcating the Exact Midplane of the Liver Using Indocyanine Green Near‐Infrared Fluorescence Imaging During Laparoscopic Donor Hepatectomy	11
Long‐Term Safety and Efficacy of Pure Laparoscopic Donor Hepatectomy in Pediatric Living Donor Liver Transplantation	11
Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant	11
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis	11
Systematic review and meta-analysis of open versus laparoscopy-assisted versus pure laparoscopic versus robotic living donor hepatectomy	10
National experience with living donor liver transplantation for hepatocellular carcinoma	10
Combined liver transplantation and sleeve gastrectomy: Report of a brief‐interval staged approach	10
Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access	10
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	10
Acute Graft‐Versus‐Host Disease After Orthotopic Liver Transplantation	10
Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation	10
Use of neural network models to predict liver transplantation waitlist mortality	10
Utility of phosphatidylethanol testing in liver transplant evaluation: examining concordance to self-reported alcohol use	10
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	10
Coagulopathy and hemostasis management in patients undergoing liver transplantation	10
Platelets Stimulate Liver Regeneration in a Rat Model of Partial Liver Transplantation	10
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma	10
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation	10
Black Race Is Associated With Higher Rates of Early‐Onset End‐Stage Renal Disease and Increased Mortality Following Liver Transplantation	10
Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients	10
Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation	9
Molecular Mismatch Predicts T Cell–Mediated Rejection and De Novo Donor‐Specific Antibody Formation After Living Donor Liver Transplantation	9
Malnutrition in Biliary Atresia	9
Acute‐on‐Chronic Liver Failure and Liver Transplantation: Putting the Cart Before the Horse in Data Analyses and Advocating for Model for End‐Stage Liver Disease Exceptions	9
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation	9

Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5‐Year Follow‐Up	9
Pediatric acute liver failure: Reexamining key clinical features, current management, and research prospects	9
Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies	9
Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients	9
Multicenter, Double‐Blind, Randomized Trial of Emricasan in Hepatitis C–Treated Liver Transplant Recipients With Residual Fibrosis or Cirrhosis	9
Practices and Perceptions of Living Donor Liver Transplantation, Nondirected Donation, and Liver Paired Exchange	9
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: A Qualitative Analysis of Hepatologist and Palliative Care Provider Views	9
Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation	9
Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation	9
Burnout Among Transplant Hepatologists in the United States	9
CAQ Corner	8
Temporal Trends and Evolving Outcomes After Simultaneous Liver‐Kidney Transplantation: Results from the US SLKT Consortium	8
Coronavirus Disease 2019 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive?	8
Implementing a Height‐Based Rule for the Allocation of Pediatric Donor Livers to Adults: A Liver Simulated Allocation Model Study	8
Prediction of long‐term morbidity and mortality after liver transplantation using two‐dimensional shear wave elastography compared with liver biopsy	8
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	8
Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort	8
A randomized, controlled, prehabilitation intervention to maximize early recovery (PRIMER) in liver transplantation	8
Improvements in Disease‐Specific Health‐Related Quality of Life of Pediatric Liver Transplant Recipients During Immunosuppression Withdrawal	8
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	8
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States	8
Donor–recipient human leukocyte antigen A mismatching is associated with hepatic artery thrombosis, sepsis, graft loss, and reduced survival after liver transplant	8
Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in liver transplant recipients	8
Characterization of social determinants of health of a liver transplant referral population	8
New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia	8
Risk factors for antibody-mediated rejection in ABO blood-type incompatible and donor-specific antibody-positive liver transplantation	8
Definition and measurement of alcohol-associated insight in early liver transplantation for acute alcohol-associated hepatitis: A systematic review	8
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients	8
A Multicentric Experience on Living Donor Liver Transplantation in Coronavirus Disease 2019 Hotspots in India	8
Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post–Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study	8
Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation	7
Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices	7
Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia	7
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis	7
Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation	7
Impact of Payer Status on Delisting Among Liver Transplant Candidates in the United States	7
The trends in cost associated with liver transplantation in the US: Analysis of weighted hospital data	7
Outcome of Extended Right Lobe Liver Transplantations	7
Graft aberrant hepatic arteries in deceased donor liver transplantation: The “one liver, one artery” approach	7
Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications	7
International Population Study in Spain, Cuba, and the United States of Attitudes Toward Organ Donation Among the Cuban Population	7
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	7
Telemedicine in Hepatology: Current Applications and Future Directions	7
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients	7
Hepatic steatosis after liver transplantation: a systematic review and meta-analysis	7
Surgical Techniques and Outcomes of Pure Laparoscopic Donor Right Posterior Sectionectomy for Living Donor Liver Transplantation	7
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	7
Alcohol Consumption the Day of Liver Transplantation for Alcohol‐Associated Liver Disease Does Not Affect Long‐Term Survival: A Case‐Control Study	7
The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice	7
Intensive locoregional therapy before liver transplantation for colorectal cancer liver metastasis: A novel pretransplant protocol	7
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	7
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	7
Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting	7
Pregnancy Outcomes After Living Liver Donation: A Multi‐Institutional Study	7
Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients	7
Liver Transplantation for Langerhans Cell Histiocytosis: A US Population‐Based Analysis and Systematic Review of the Literature	7
Applying Administrative Data‐Based Coding Algorithms for Frailty in Patients With Cirrhosis	7
Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	7
Acute cellular rejection in liver transplantation recipients following vaccination against coronavirus disease 2019: A case series	6
Neonates with acute liver failure have higher overall mortality but similar posttransplant outcomes as older infants	6
Early experiences with developing techniques for pure laparoscopic explant hepatectomy in living donor liver transplantation	6
Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high‐volume transplant center	6
Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series	6
Liver Transplantation in Short Telomere‐Mediated Hepatopulmonary Syndrome Following Bone Marrow Transplantation Using HCV Positive Allografts: A Case Series	6
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissection in Living Donor Liver Transplantation	6
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	6
Long‐term outcome of primary percutaneous stent angioplasty for pediatric posttransplantation portal vein stenosis	6
North American Biliary Stricture Management Strategies in Children After Liver Transplantation	6
Decreased Long‐Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019	6
The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol‐Associated Hepatitis	6
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	6
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	6
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	6
A Tale Full of Sound and Fury	6
Assessment of human leukocyte antigen matching algorithm PIRCHE‐II on liver transplantation outcomes	6
Mycophenolate mofetil discontinuation increases severe acute respiratory syndrome coronavirus 2 vaccine response in nonresponder liver transplantation recipients: A proof of concept	6
A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation	6
Liver Retransplantation Using Living Donor Grafts	6
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	6
Cost‐Effectiveness of Primary Liver Transplantation Versus Hepatoportoenterostomy in the Management of Biliary Atresia in the United States	6
Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors	6
Waitlist and posttransplantation outcomes of lean individuals with nonalcoholic fatty liver disease	6
Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody–Positive Liver Grafts	6
Long‐term follow‐up of living liver donors	5
Heterogeneity of hepatic steatosis definitions and reporting of donor liver frozen sections among pathologists	5
Beware of Portal Vein Thrombosis After Laparoscopic Sleeve Gastrectomy in Liver Transplant Recipients	5
Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein	5
Optimizing Liver Division Technique for Procuring Left Lateral Segment Grafts: New Anatomical Insights	5
Lower Alpha‐Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma	5
Posttransplant Hemophagocytic Lymphohistiocytosis in Pediatric Liver Transplant Recipients	5
The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction	5
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
Management of Biliary Stricture in Pediatric Liver Transplantation Patients: Long‐Term Outcomes	5
Assessing reliability and validity of SIPAT and opportunities for improvement: A single-center cohort study	5
Postoperative fibrinolytic resistance is associated with early allograft dysfunction in liver transplantation: A prospective observational study	5